Spectrum Pharmaceuticals Statistics Share Statistics Spectrum Pharmaceuticals has 205.25M
shares outstanding. The number of shares has increased by 30.5%
in one year.
Shares Outstanding 205.25M Shares Change (YoY) 30.5% Shares Change (QoQ) 12.84% Owned by Institutions (%) n/a Shares Floating 170.57M Failed to Deliver (FTD) Shares 2,938 FTD / Avg. Volume 0.18%
Short Selling Information The latest short interest is 2.96M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.96M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.78
Valuation Ratios The PE ratio is -0.86 and the forward
PE ratio is null.
Spectrum Pharmaceuticals's PEG ratio is
0.01.
PE Ratio -0.86 Forward PE n/a PS Ratio 6.68 Forward PS n/a PB Ratio 2.42 P/FCF Ratio -0.69 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Spectrum Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.37,
with a Debt / Equity ratio of 1.06.
Current Ratio 2.37 Quick Ratio 2.15 Debt / Equity 1.06 Debt / EBITDA -0.38 Debt / FCF -0.3 Interest Coverage -72.84
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $117.6K Profits Per Employee $-908.19K Employee Count 86 Asset Turnover 0.1 Inventory Turnover 0.19
Taxes Income Tax 46K Effective Tax Rate -0.06%
Stock Price Statistics The stock price has increased by -0.97% in the
last 52 weeks. The beta is 2.14, so Spectrum Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.14 52-Week Price Change -0.97% 50-Day Moving Average 1.03 200-Day Moving Average 0.75 Relative Strength Index (RSI) 56.79 Average Volume (20 Days) 1,642,309
Income Statement In the last 12 months, Spectrum Pharmaceuticals had revenue of 10.11M
and earned -78.1M
in profits. Earnings per share was -0.43.
Revenue 10.11M Gross Profit 8.32M Operating Income -72.7M Net Income -78.1M EBITDA -77.06M EBIT -77.03M Earnings Per Share (EPS) -0.43
Full Income Statement Balance Sheet The company has 40.37M in cash and 29.43M in
debt, giving a net cash position of 10.94M.
Cash & Cash Equivalents 40.37M Total Debt 29.43M Net Cash 10.94M Retained Earnings -1.12B Total Assets 107.67M Working Capital 66.5M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -96.99M
and capital expenditures -273K, giving a free cash flow of -97.26M.
Operating Cash Flow -96.99M Capital Expenditures -273K Free Cash Flow -97.26M FCF Per Share -0.53
Full Cash Flow Statement Margins Gross margin is 82.28%, with operating and profit margins of -718.78% and -772.24%.
Gross Margin 82.28% Operating Margin -718.78% Pretax Margin -771.78% Profit Margin -772.24% EBITDA Margin -761.91% EBIT Margin -718.78% FCF Margin -961.66%
Dividends & Yields SPPI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SPPI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 6, 2002. It was a
backward
split with a ratio of 1:25.
Last Split Date Sep 6, 2002 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -14.03 Piotroski F-Score 3
